167 related articles for article (PubMed ID: 26891979)
1. Dendrimer technologies for brain tumor.
Mishra V; Kesharwani P
Drug Discov Today; 2016 May; 21(5):766-78. PubMed ID: 26891979
[TBL] [Abstract][Full Text] [Related]
2. Dendrimer-mediated approaches for the treatment of brain tumor.
Dwivedi N; Shah J; Mishra V; Mohd Amin MC; Iyer AK; Tekade RK; Kesharwani P
J Biomater Sci Polym Ed; 2016; 27(7):557-80. PubMed ID: 26928261
[TBL] [Abstract][Full Text] [Related]
3. Dendrimer nanoarchitectures for cancer diagnosis and anticancer drug delivery.
Sharma AK; Gothwal A; Kesharwani P; Alsaab H; Iyer AK; Gupta U
Drug Discov Today; 2017 Feb; 22(2):314-326. PubMed ID: 27671487
[TBL] [Abstract][Full Text] [Related]
4. Dendrimers as vectors for genetic material delivery to the nervous system.
Pérez-Martínez FC; Ocaña AV; Pérez-Carrión MD; Ceña V
Curr Med Chem; 2012; 19(29):5101-8. PubMed ID: 22963638
[TBL] [Abstract][Full Text] [Related]
5. Analysis of biotinylated generation 4 poly(amidoamine) (PAMAM) dendrimer distribution in the rat brain and toxicity in a cellular model of the blood-brain barrier.
Hemmer R; Hall A; Spaulding R; Rossow B; Hester M; Caroway M; Haskamp A; Wall S; Bullen HA; Morris C; Haik KL
Molecules; 2013 Sep; 18(9):11537-52. PubMed ID: 24048286
[TBL] [Abstract][Full Text] [Related]
6. Perillyl Alcohol and Its Drug-Conjugated Derivatives as Potential Novel Methods of Treating Brain Metastases.
Chen TC; Da Fonseca CO; Schönthal AH
Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27598140
[TBL] [Abstract][Full Text] [Related]
7. A dual-targeting nanocarrier based on poly(amidoamine) dendrimers conjugated with transferrin and tamoxifen for treating brain gliomas.
Li Y; He H; Jia X; Lu WL; Lou J; Wei Y
Biomaterials; 2012 May; 33(15):3899-908. PubMed ID: 22364698
[TBL] [Abstract][Full Text] [Related]
8. PAMAM Dendrimers Cross the Blood-Brain Barrier When Administered through the Carotid Artery in C57BL/6J Mice.
Srinageshwar B; Peruzzaro S; Andrews M; Johnson K; Hietpas A; Clark B; McGuire C; Petersen E; Kippe J; Stewart A; Lossia O; Al-Gharaibeh A; Antcliff A; Culver R; Swanson D; Dunbar G; Sharma A; Rossignol J
Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28335421
[TBL] [Abstract][Full Text] [Related]
9. Nanoscale effects in dendrimer-mediated targeting of neuroinflammation.
Nance E; Zhang F; Mishra MK; Zhang Z; Kambhampati SP; Kannan RM; Kannan S
Biomaterials; 2016 Sep; 101():96-107. PubMed ID: 27267631
[TBL] [Abstract][Full Text] [Related]
10. Imaging brain tumor by dendrimer-based optical/paramagnetic nanoprobe across the blood-brain barrier.
Yan H; Wang J; Yi P; Lei H; Zhan C; Xie C; Feng L; Qian J; Zhu J; Lu W; Li C
Chem Commun (Camb); 2011 Jul; 47(28):8130-2. PubMed ID: 21629879
[TBL] [Abstract][Full Text] [Related]
11. Recent Advances in Preclinical Studies and Potential Applications of Dendrimers as Drug Carriers in the Central Nervous System.
Gagliardi M
Curr Pharm Des; 2017; 23(21):3105-3119. PubMed ID: 28294054
[TBL] [Abstract][Full Text] [Related]
12. The targeted delivery of cancer drugs across the blood-brain barrier: chemical modifications of drugs or drug-nanoparticles?
Juillerat-Jeanneret L
Drug Discov Today; 2008 Dec; 13(23-24):1099-106. PubMed ID: 18848640
[TBL] [Abstract][Full Text] [Related]
13. Dendrimer grafted albumin nanoparticles for the treatment of post cerebral stroke damages: A proof of concept study.
Pradhan D; Tambe V; Raval N; Gondalia P; Bhattacharya P; Kalia K; Tekade RK
Colloids Surf B Biointerfaces; 2019 Dec; 184():110488. PubMed ID: 31541894
[TBL] [Abstract][Full Text] [Related]
14. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.
van Tellingen O; Yetkin-Arik B; de Gooijer MC; Wesseling P; Wurdinger T; de Vries HE
Drug Resist Updat; 2015 Mar; 19():1-12. PubMed ID: 25791797
[TBL] [Abstract][Full Text] [Related]
15. Improving the transport of chemotherapeutic drugs across the blood-brain barrier.
Orthmann A; Fichtner I; Zeisig R
Expert Rev Clin Pharmacol; 2011 Jul; 4(4):477-90. PubMed ID: 22114857
[TBL] [Abstract][Full Text] [Related]
16. Uniform brain tumor distribution and tumor associated macrophage targeting of systemically administered dendrimers.
Zhang F; Mastorakos P; Mishra MK; Mangraviti A; Hwang L; Zhou J; Hanes J; Brem H; Olivi A; Tyler B; Kannan RM
Biomaterials; 2015 Jun; 52():507-16. PubMed ID: 25818456
[TBL] [Abstract][Full Text] [Related]
17. Dendrimer-based nanoparticles for cancer therapy.
Baker JR
Hematology Am Soc Hematol Educ Program; 2009; ():708-19. PubMed ID: 20008257
[TBL] [Abstract][Full Text] [Related]
18. Dendrimer toxicity: Let's meet the challenge.
Jain K; Kesharwani P; Gupta U; Jain NK
Int J Pharm; 2010 Jul; 394(1-2):122-42. PubMed ID: 20433913
[TBL] [Abstract][Full Text] [Related]
19. Advances in Molecular Imaging of Locally Delivered Targeted Therapeutics for Central Nervous System Tumors.
Tosi U; Marnell CS; Chang R; Cho WC; Ting R; Maachani UB; Souweidane MM
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28208698
[TBL] [Abstract][Full Text] [Related]
20. Nanoparticle-mediated brain-specific drug delivery, imaging, and diagnosis.
Yang H
Pharm Res; 2010 Sep; 27(9):1759-71. PubMed ID: 20593303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
